Recent Company News

• 02:01 AM ET Oct 08, 2026
  

  Ceryvyn Therapeutics holder Jagen Nominees increases holding to 16.56% from 12.45% - Form 604 (A$0.01, 0.00)

• 12:58 AM ET Sep 15, 2026
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (54 total)

• 12:58 AM ET Sep 07, 2026
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (28 total)

• 09:49 PM ET Aug 27, 2026
  

  StreetAccount Summary - Australia unusual volume traders

• 12:52 AM ET Sep 04, 2026
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (29 total)

• 12:51 AM ET Sep 01, 2026
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (44 total)

• 04:51 AM ET Aug 31, 2026
  

  Ceryvyn Therapeutics reports FY net income attributable A$330.4M vs FactSet A$327.6M [1 est] (A$0.01, 0.00)

• 12:57 AM ET Aug 31, 2026
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (34 total)

• 12:57 AM ET Aug 28, 2026
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (41 total)